A New Era of Patient-Led Innovation
Patient groups oftentimes serve as the authority on a specific disease when it comes to advancing research.…
innovation
A Framework for R&D Investment and Innovation in…
Although the Turkish pharmaceutical market has grown significantly in recent years R&D investment remains comparatively low. However, the expertise and capabilities exist for growth in this sector. Turkish companies and…
Korea: Prioritising AI in Healthcare Innovation
The South Korean government has designated the promotion of artificial intelligence (AI)-based drug development and…
Kobe: A Center of Excellence for Biomedical Innovation
Kenichi Tamiya, director for Biomedical Policy at the Kobe City Government and managing director of the Kobe…
In Conversation
Dar-Bin Shieh – Deputy Minister of Science and Technology, Republic of China (Taiwan)
Dar-Bin Shieh, deputy minister of science and technology of the Republic of China (Taiwan), gives an overview of Biomedical Industry Innovation Program, enacted to bolster Taiwan’s biomedical and biotechnology sectors as part of the 5+2 Industrial Innovation Plan. Deputy Minister Shieh also elaborates on how Taiwan’s unique strengths in ICT, infrastructure, and talent will help drive forward the country’s position…
The Greater Bay Area (Guangdong, Hong Kong, Macau) Macroeconomic Snapshot
The Greater Bay Area (several cities in Guangdong Province in mainland China along with Hong Kong and Macau) is a…
Related Report
IP in China: From Imitation to Innovation
The Greater Bay Area’s – and in particular, Shenzhen’s – prowess in life sciences manufacturing…
Japan: Reforming Healthcare in the Age of Ageing
Japan’s Opportunity to Establish a Blueprint for the World: Janssen Japan’s Chris Hourigan makes the case…
“Canada Needs to do Better in Supporting Innovative Biopharma”
Brian Hilberdink, President of Novo Nordisk Canada, calls for the Canadian government to encourage and invest in…
Austria: Orchestrating Innovation
Austria has long been merely a cog in the wheel of global R&D, lying in the shadows of neighboring research…
The Netherlands: A Fertile Garden for Innovation
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by…
China’s Greater Bay Area: Spearheading Innovation
Guangdong province and neighbouring Hong Kong have long been fundamental to China’s metamorphosis into an…
Stockholm: A Hidden Jewel of Life Sciences Innovation in Europe
Some of the key stakeholders in Swedish healthcare and life sciences outline why they feel Sweden’s capital,…
Digital and Advanced Analytics: From Hype to Tipping Point in R&D
Martin Dewhurst, co-leader for McKinsey’s global Pharmaceuticals and Medical Products Practice, discusses the…
Beyond the Pill — Pharma Takes a Stake In Digital Health
Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the…
Australia – Innovation Down Under
Australia, the “land down under” to many Westerners, is sometimes left at just that — out of sight,…
Regulatory Science Struggling to Keep Pace with Innovation
While drug developers, healthcare practitioners and patients all rejoice at the advent of a golden age of…
The future of innovation in Ireland
“If you look at the cuts in the public sector, the science budget has been relatively lightly touched. This sends…
Portuguese generics: headroom for innovation?
In PharmaBoardroom’s first coverage of Portugal in 2007, generics represented 16 percent of the country’s…
Switzerland: A Hotbed of Innovation
Switzerland’s especially fine reputation for research impact and innovation generation is attracting a host of…
We Need to Talk About Pharma Profits
Brendan Shaw is principal at Shawview Consulting, a specialised consulting and advisory firm for public and…
Dutch Healthcare: “Innovation with Collaboration”
In keeping with its reputation as a forerunner, the Dutch healthcare eco-system is currently reinventing itself to…
Bridging Data Access Gaps to Drive Innovation in Biopharma
Tom Achoki of Mass Sciences explores the possibilities that better access to high-quality real-world data will…
Blockchain for Healthcare: Hero or Hype?
Joonho J. Lee is a CEO and CoFounder of Cognita Lab INC developing risk management framework around Artificial…
Showcasing South African innovation
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem…
“Why We Need Public-Private Partnerships in Drug R&D”
Pierre Meulien, Executive Director of the Innovative Medicines Initiative (IMI) in Europe, outlines the value of…
Netherlands: Innovation Through Collaboration
Despite its diminutive size, the Netherlands has historically carried a large weight in the world because of…
The Technology Driving Rare Disease Pipelines
Rhenu Buller, an expert on disruptive technologies at business consultancy Frost & Sullivan’s Asia…
NEW Korea Pharma Report Out Now
One of the indisputable economic success stories of the last half-century, South Korea now stands as the world’s…
Speeding Up Access to Innovation in Portugal
A new regulation is helping Portugal’s market access conditions for pharmaceuticals catch up with those of other…
AI and Machine Learning Takes on the Burden of Billing and Coding
Meghann Chilcott, Senior Vice President of OrderInsite, looks at how new technology is being applied to improve…
Promoting Japanese Bio-industry Innovation
Prof. Yoshiaki Tsukamoto, executive director of the Japan Bioindustry Association (JBA), talked exclusively to…
65 Years of Promoting Pharmaceutical Innovation in Mexico
In order to mark its 65th anniversary, the Mexican Association of Pharmaceutical Research Industries (AMIIF)…
Tattoo Sensor Technology: The Future of Maltese Innovation?
UMANA T1 – a patient monitoring ecosystem that uses tattoo sensor technology to measure and record heart rate and…